X-linked Adrenal Hypoplasia Congenita: report of two families and a new NR0B1 mutation by Pereira, Bernardo D. et al.
X-linked Adrenal Hypoplasia Congenita: report of two families and a new 
NR0B1 mutation  
 
Bernardo D Pereira1, Tiago S Nunes1, Henrique V Luiz1 , Andreia Veloza1, 
Catarina Matos1, Isabel Manita1, Maria C Cordeiro1, João Gonçalves2, Luísa 
Raimundo1, Jorge Portugal1 
 
1Serviço de Endocrinologia e Diabetologia, Hospital Garcia de Orta, E.P.E., 
Almada, Portugal  
2Departamento de Genética Humana, Instituto Nacional de Saúde Doutor Ricardo 
Jorge, I.P., Lisboa, Portugal 
 
Disclosure information: nothing to disclose.  
 
Background: 
 X-linked Adrenal Hypoplasia Congenita (X-linked AHC) tipically manifests 
as adrenal insufficiency in a bimodal clinical presentation (5–60 days and 2–13 
years) and, at pubertal age, hypogonadotropic hypogonadism (HH) in males. It is 
caused by mutations in NR0B1 (present in Xp21.2), a gene with a critical role in 
the development of adrenals and hypothalamic-pituitary-gonadal (HPG) axis. It 
represents ~1% of all causes of primary adrenal insufficiency under age 18. We 
present two kindreds with NR0B1 mutations, one with a previously unreported 
mutation.  
Clinical case - family A: 
 The proband presented with adrenal crisis at day 18 of life. Family history 
was relevant for an uncle death as a newborn. Hormonal assays revealed 
elevated ACTH (34,5 pmol/L, reference: <11), normal cortisol (220.8 nmol/L, 
reference: 56-665) and androgens (17-OHP: 9.9 nmol/L, reference: 7.5-24.6; 11-
deoxycortisol: 83.52 nmol/L, reference: 47.9-260.9;), which showed no response 
to ACTH stimulation test and progressed to undectetable levels on serial 
measurements. From 6,8 years-old (yo) to 14 yo his height curve crossed from -
0,1SD to -1,86SD, and at 14,1 yo testicular volume was 3mL. His gonadotropins 
(FSH 0.95 UI/L; LH <0.1 UI/L), total testosterone (TT, <0.35 nmol/L; reference: 
0.5-17.5) and GnRH test (LH - basal: <0.1 UI/L; peak: 0.8 UI/L; FSH - basal: 0.67 
UI/L; peak: 1.9 UI/L) confirming HH. Molecular analysis of the NR0B1 gene 
revealed the mutation c.1084A>T, leading to a premature stop codon, p.Lys362*, 
in exon 1. His mother and sister were both asymptomatic carriers for this 
mutation. This mutation, not described previously, leads probably to a non-
functional truncated protein. 
Clinical case - family B: 
 Kindred B had two males who presented with adrenal crisis at the 
newborn age (proband: 14 days; brother: 16 days). At 6 months of age, the 
proband had elevated ACTH (193.2 pmol/L, reference: <11) and elevated levels 
of cortisol (634 nmol/L, reference: 107-405) and 17-OHP (15.2 nmol/L; 
reference: 1.55-5.03), with no increase at Synacthen  test (peak cortisol: 635 
nmol/L; peak 17-OHP: 11.5 nmol/L). His affected brother had also elevated 17-
OHP at presentation (48.5 nmol/L, reference: 7.5-24.6), but beyond the 1st year 
poor compliance with replacement therapy revealed persistently elevated ACTH 
(249.3 pmol/L) and undectectable androgens (17-OHP: <0,3 nmol/L; 
androstenedione <1 nmol/L; DHEA-S <0,27 nmol/L). Both cases had delayed 
bone age at 9 months (proband: 6 months of chronologic age) and 2 years 
(brother: 2,6 years of chronologic age). At 14 yo they had pubertal Tanner stage 
1. Basal gonadotropin and TT levels were also prebubertal (proband: FSH 2.61 
UI/L; LH <0.1 UI/L; TT <0.35, reference: 0.5-17.5; brother: FSH 0.4 UI/L; LH <0.1 
UI/L; TT <0.35 nmol/L). NR0B1 molecular analysis allowed the identification of 
the nonsense mutation, c.234C>G; p.Tyr81*, in exon 1, present in the two 
affected males. His mother and one sister were also asymptomatic carriers.   
 
Conclusion: Our kindreds highlights the clinical aspects of the rare X-linked AHC 
and its challenging differential diagnosis. The diagnosis was based on …. 
Completar … and an apparently X-linked mode of inheritance. Molecular analysis 
of the NR0B1 gene allowed the identification of the molecular defect in both 
families. Two different nonsense mutation in exon 1 were identified, giving rise 
most probably to truncated non-functional proteins, confirming the disease 
severity or the clinical phenotype of the affected boys. Mutation identification 
was relevant for genetic counseling of the parents, as well as for the patient’s 
sisters.   
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Case rp mc 
Age 19 days 6 months 
17-
hydroxyprogesterone  
9,9 (ref. 7,5-24,6) 15,2 (1,55-5,03) 
11-deoxycortisol 83,52 (ref. 47,9-260,9) 11,5 (4,11-22,6) 
Androstenedione 25,12 (ref. 0,63-5,9) 4,2 (0,21-1,05) 
Cortisol 220,8 (ref. 55,5-664,7) 634,5 (107,4-404,9 
ACTH   193,2 
 
 
